Gene therapy faces complexities in delivering treatments due to persistent safety concerns and daunting immune responses, but Next Generation Gene Therapeutics Inc. has found a way around this issue using dual-functional vectors to simultaneously remove harmful, mutated genes and replace them with normal, healthy genes to restore cellular function.
Tamra Sami is a science writer, editor, and publication manager with expertise in product development, particularly in Asia and emerging markets. As a staff writer for Bioworld co., Tamra focuses on covering a wide range of topics in the field of biotechnology, including advancements in precision health, clinical trial results, licensing deals, and emerging therapies.